Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque PsoriasisSkin Diseases, Papulosquamous, Skin and Connective Tissue Diseases, psoriasis, skin disorderActive, not recruitingPhase 32026-09-18NCT06425549

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
UCB Biopharma SRL30

42 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ps0021 20033NagoyaJapan1
Ps0021 20071NagasakiJapan1
Ps0021 20337Shimotsuga-gunJapan1
Ps0021 40023ErlangenGermany1
Ps0021 40085PisaItaly1
Ps0021 40091Nowa SólPoland1
Ps0021 40121BrusselsBelgium1
Ps0021 40138BonnGermany1
Ps0021 40177MünsterGermany1
Ps0021 40249KielGermany1
Ps0021 40334WroclawPoland1
Ps0021 40356DresdenGermany1
Ps0021 40440Ancona, Località TorretteItaly1
Ps0021 40515BerlinGermany1
Ps0021 40567RomaItaly1
Ps0021 40625LodzPoland1
Ps0021 40645Frankfurt am MainGermany1
Ps0021 40737RzeszówPoland1
Ps0021 40738WroclawPoland1
Ps0021 40740Bad BentheimGermany1
Ps0021 40741BialystokPoland1
Ps0021 40743SzczecinPoland1
Ps0021 40744KaposvárHungary1
Ps0021 40745SzegedHungary1
Ps0021 40746DebrecenHungary1